Michael David Garrison's most recent trade in Becton, Dickinson And Co. was a trade of 3,054 Common Stock done at an average price of $167.9 . Disclosure was reported to the exchange on Jan. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Becton, Dickinson and Co. | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 167.91 per share. | 15 Jan 2026 | 3,054 | 16,159 (0%) | 0% | 167.9 | 512,797 | Common Stock |
| Becton, Dickinson and Co. | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jan 2026 | 3,054 | 0 | - | - | Stock Appreciation Rights | |
| Becton, Dickinson and Co. | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale or transfer of securities back to the company at price $ 209.00 per share. | 15 Jan 2026 | 2,454 | 13,705 (0%) | 0% | 209 | 512,886 | Common Stock |
| Becton, Dickinson and Co. | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale of securities on an exchange or to another person at price $ 206.54 per share. | 15 Jan 2026 | 1,010 | 12,095 (0%) | 0% | 206.5 | 208,605 | Common Stock |
| Becton, Dickinson and Co. | Michael David Garrison | EVP & Pres Med.Essntl&BioPharm | Sale of securities on an exchange or to another person at price $ 209.00 per share. | 15 Jan 2026 | 600 | 13,105 (0%) | 0% | 209 | 125,400 | Common Stock |